{"protocolSection": {"identificationModule": {"nctId": "NCT04868500", "orgStudyIdInfo": {"id": "N4280000000"}, "organization": {"fullName": "AstraZeneca", "class": "INDUSTRY"}, "briefTitle": "Managing Asthma Patients With AMAZE\u2122: A Novel Disease Management Platform", "officialTitle": "Managing Asthma Patients With AMAZE\u2122: A Novel Disease Management Platform, A Clinical Pilot Study"}, "statusModule": {"statusVerifiedDate": "2023-01", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2021-04-27", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2021-11-30", "type": "ACTUAL"}, "completionDateStruct": {"date": "2021-11-30", "type": "ACTUAL"}, "studyFirstSubmitDate": "2021-03-17", "studyFirstSubmitQcDate": "2021-04-27", "studyFirstPostDateStruct": {"date": "2021-05-03", "type": "ACTUAL"}, "resultsFirstSubmitDate": "2022-11-29", "resultsFirstSubmitQcDate": "2023-01-16", "resultsFirstPostDateStruct": {"date": "2023-02-08", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2023-01-16", "lastUpdatePostDateStruct": {"date": "2023-02-08", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "AstraZeneca", "class": "INDUSTRY"}, "collaborators": [{"name": "Massachusetts General Hospital", "class": "OTHER"}, {"name": "Evidera", "class": "INDUSTRY"}]}, "oversightModule": {"isFdaRegulatedDrug": false, "isFdaRegulatedDevice": true}, "descriptionModule": {"briefSummary": "The primary study objective is to generate evidence as to the feasibility, usability, perceived value, and potential benefits of implementing the AMAZE\u2122 platform into clinical practice.", "detailedDescription": "AstraZeneca has developed the AMAZE\u2122 disease management platform to be used across multiple disease indications to provide a unified experience for the management of participants throughout their participant care journey. AMAZE\u2122 integrates multiple systems, including a patient mobile application where patients can enter daily symptoms and impact to communicate this information to their healthcare provider, as well as access disease educational materials. Implementation of AMAZE\u2122 within clinical practice has not yet been evaluated. The results from this study will be used to inform any changes or modifications that need to be made to the technology platform, its implementation process, and explore impact on clinical outcomes."}, "conditionsModule": {"conditions": ["Asthma"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["NA"], "designInfo": {"allocation": "NON_RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "HEALTH_SERVICES_RESEARCH", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 49, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Massachusetts General Hospital (MGH) Participants", "type": "EXPERIMENTAL", "description": "Participants will use the AMAZE\u2122 application to enter daily asthma symptoms and impact to communicate this information to their healthcare provider, as well as access disease educational materials up to six months.", "interventionNames": ["Device: AMAZE\u2122 Application"]}, {"label": "Massachusetts General Hospital (MGH) Clinical Site Staff", "type": "EXPERIMENTAL", "description": "Clinical site staff will use the AMAZE\u2122 dashboard for six months to identify usability and barriers, benefits, challenges, ease of implementation, and areas for improvement of the AMAZE\u2122 dashboard in a clinical setting.", "interventionNames": ["Device: AMAZE\u2122 Dashboard"]}], "interventions": [{"type": "DEVICE", "name": "AMAZE\u2122 Application", "description": "Participants will use the AMAZE\u2122 application to enter daily asthma symptoms and impact to communicate this information to their healthcare provider, as well as access disease educational materials up to six months.", "armGroupLabels": ["Massachusetts General Hospital (MGH) Participants"]}, {"type": "DEVICE", "name": "AMAZE\u2122 Dashboard", "description": "Clinical site staff will use the AMAZE\u2122 dashboard for six months to identify usability and barriers, benefits, challenges, ease of implementation, and areas for improvement of the AMAZE\u2122 dashboard in a clinical setting.", "armGroupLabels": ["Massachusetts General Hospital (MGH) Clinical Site Staff"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Number of Days Participants Accessed the AMAZE\u2122 App (Weeks 1 to 4)", "description": "Participant App usage was measured as the number of days the participant engaged (ie., participants accessed 'Home, Daily asthma log, Air quality, My plan, Trends, Appointments, Educational material, Messages, and Notifications') with the App during Weeks 1 to 4.", "timeFrame": "Weeks 1 to 4"}, {"measure": "Number of Days Participants Accessed the AMAZE\u2122 App (Weeks 5 to 8)", "description": "Participant App usage was measured as the number of days the participant engaged (ie., participants accessed 'Home, Daily asthma log, Air quality, My plan, Trends, Appointments, Educational material, Messages, and Notifications') with the App during Weeks 5 to 8.", "timeFrame": "Weeks 5 to 8"}, {"measure": "Number of Days Participants Accessed the AMAZE\u2122 App (Weeks 9 to 12)", "description": "Participant App usage was measured as the number of days the participant engaged (ie., participants accessed 'Home, Daily asthma log, Air quality, My plan, Trends, Appointments, Educational material, Messages, and Notifications') with the App during Weeks 9 to 12.", "timeFrame": "Weeks 9 to 12"}, {"measure": "Number of Days Participants Accessed the AMAZE\u2122 App (Weeks 13 to 16)", "description": "Participant App usage was measured as the number of days the participant engaged (ie., participants accessed 'Home, Daily asthma log, Air quality, My plan, Trends, Appointments, Educational material, Messages, and Notifications') with the App during Weeks 13 to 16.", "timeFrame": "Weeks 13 to 16"}, {"measure": "Number of Days Participants Accessed the AMAZE\u2122 App (Weeks 17 to 20)", "description": "Participant App usage was measured as the number of days the participant engaged (ie., participants accessed 'Home, Daily asthma log, Air quality, My plan, Trends, Appointments, Educational material, Messages, and Notifications') with the App during Weeks 17 to 20.", "timeFrame": "Weeks 17 to 20"}, {"measure": "Number of Days Participants Accessed the AMAZE\u2122 App (Weeks 21 to 24)", "description": "Participant App usage was measured as the number of days the participant engaged (ie., participants accessed 'Home, Daily asthma log, Air quality, My plan, Trends, Appointments, Educational material, Messages, and Notifications') with the App during Weeks 21 to 24.", "timeFrame": "Weeks 21 to 24"}, {"measure": "Number of Days Clinical Site Staff Accessed the AMAZE\u2122 Dashboard (Weeks 1 to 4)", "description": "Clinician dashboard usage was measured as the mean number of days that the clinical site staff accessed the AMAZE\u2122 dashboard during Weeks 1 to 4.", "timeFrame": "Weeks 1 to 4"}, {"measure": "Number of Days Clinical Site Staff Accessed the AMAZE\u2122 Dashboard (Weeks 5 to 8)", "description": "Clinician dashboard usage was measured as the mean number of days that the clinical site staff accessed the AMAZE\u2122 dashboard during Weeks 5 to 8.", "timeFrame": "Weeks 5 to 8"}, {"measure": "Number of Days Clinical Site Staff Accessed the AMAZE\u2122 Dashboard (Weeks 9 to 12)", "description": "Clinician dashboard usage was measured as the mean number of days that the clinical site staff accessed the AMAZE\u2122 dashboard during Weeks 9 to 12.", "timeFrame": "Weeks 9 to 12"}, {"measure": "Number of Days Clinical Site Staff Accessed the AMAZE\u2122 Dashboard (Weeks 13 to 16)", "description": "Clinician dashboard usage was measured as the mean number of days that the clinical site staff accessed the AMAZE\u2122 dashboard during Weeks 13 to 16.", "timeFrame": "Weeks 13 to 16"}, {"measure": "Number of Days Clinical Site Staff Accessed the AMAZE\u2122 Dashboard (Weeks 17 to 20)", "description": "Clinician dashboard usage was measured as the mean number of days that the clinical site staff accessed the AMAZE\u2122 dashboard during Weeks 17 to 20.", "timeFrame": "Weeks 17 to 20"}, {"measure": "Number of Days Clinical Site Staff Accessed the AMAZE\u2122 Dashboard (Weeks 21 to 24)", "description": "Clinician dashboard usage was measured as the mean number of days that the clinical site staff accessed the AMAZE\u2122 dashboard during Weeks 21 to 24.", "timeFrame": "Weeks 21 to 24"}, {"measure": "Number of Participants Engaged in Agreement of Visit Survey Item 9 (Weeks 1 to 4)", "description": "Visit Survey Item 9 was 'The visit helped avoid an emergency room (ER) or urgent care center visit or hospitalization.' Visit surveys were completed throughout the study whenever a participant completed an asthma-related clinic visit. Number of participants engaged in agreement of Visit Survey Item 9 as 'High' (ie., 5-7 days per week per month) and 'Very low' (ie., less than one day per week per month) are reported.", "timeFrame": "Weeks 1 to 4"}, {"measure": "Number of Participants Engaged in Agreement of Visit Survey Item 9 (Weeks 5 to 8)", "description": "Visit Survey Item 9 was 'The visit helped avoid an ER or urgent care center visit or hospitalization.' Visit surveys were completed throughout the study whenever a participant completed an asthma-related clinic visit. Number of participants engaged in agreement of Visit Survey Item 9 as 'High' (ie., 5-7 days per week per month) and 'Very low' (ie., less than one day per week per month) are reported.", "timeFrame": "Weeks 5 to 8"}, {"measure": "Number of Participants Engaged in Agreement of Visit Survey Item 9 (Weeks 9 to 12)", "description": "Visit Survey Item 9 was 'The visit helped avoid an ER or urgent care center visit or hospitalization.' Visit surveys were completed throughout the study whenever a participant completed an asthma-related clinic visit. Number of participants engaged in agreement of Visit Survey Item 9 as 'High' (ie., 5-7 days per week per month) and 'Very low' (ie., less than one day per week per month) are reported.", "timeFrame": "Weeks 9 to 12"}, {"measure": "Number of Participants Engaged in Agreement of Visit Survey Item 9 (Weeks 13 to 16)", "description": "Visit Survey Item 9 was 'The visit helped avoid an ER or urgent care center visit or hospitalization.' Visit surveys were completed throughout the study whenever a participant completed an asthma-related clinic visit. Number of participants engaged in agreement of Visit Survey Item 9 as 'High' (ie., 5-7 days per week per month) and 'Very low' (ie., less than one day per week per month) are reported.", "timeFrame": "Weeks 13 to 16"}, {"measure": "Number of Participants Engaged in Agreement of Visit Survey Item 9 (Weeks 17 to 20)", "description": "Visit Survey Item 9 was 'The visit helped avoid an ER or urgent care center visit or hospitalization.' Visit surveys were completed throughout the study whenever a participant completed an asthma-related clinic visit. Number of participants engaged in agreement of Visit Survey Item 9 as 'High' (ie., 5-7 days per week per month) and 'Very low' (ie., less than one day per week per month) are reported.", "timeFrame": "Weeks 17 to 20"}, {"measure": "Number of Participants Engaged in Agreement of Visit Survey Item 9 (Weeks 21 to 24)", "description": "Visit Survey Item 9 was 'The visit helped avoid an ER or urgent care center visit or hospitalization.' Visit surveys were completed throughout the study whenever a participant completed an asthma-related clinic visit. Number of participants engaged in agreement of Visit Survey Item 9 as 'High' (ie., 5-7 days per week per month) and 'Very low' (ie., less than one day per week per month) are reported.", "timeFrame": "Weeks 21 to 24"}, {"measure": "Evaluate Participant Satisfaction With the AMAZE\u2122 App (End of Study)", "description": "Satisfaction with the AMAZE\u2122 App features was measured by the number of participants who reported satisfaction on parameters of 'Very unsatisfied, Unsatisfied, Neutral, Satisfied, and Very satisfied'.", "timeFrame": "End of Study (Month 6)"}, {"measure": "Emergency Room Visits, Urgent Care Center Visits, or Hospitalization Avoidance (End of Study)", "description": "The impact of AMAZE\u2122 on ER, urgent care center visits, and hospitalizations was measured as the number of participants who reported \"agree\" or \"strongly agree\" with the question 'Since the start of the study, use of the AMAZE\u2122 App helped me avoid ER or urgent care center visits or hospitalizations.' from the participant visit experience survey.", "timeFrame": "End of Study (Month 6)"}, {"measure": "Impact of AMAZE\u2122 App on Participants Clinic Visits", "description": "Visit Survey Item 9 was 'The visit helped avoid an ER or urgent care center visit or hospitalization.' The impact of AMAZE\u2122 on participant visits was measured as the number of participants who selected \"agree\" or \"strongly agree\" in response to the 9-items in the participant visit experience survey.", "timeFrame": "Day 1 through End of Study (Month 6)"}, {"measure": "Participant Perception of Appointment Discussions and Taking Part in Asthma Decisions (End of Study)", "description": "The impact of AMAZE\u2122 on improved participant communication with their healthcare provider was measured as the number of participants who reported \"agree\" or \"strongly agree\" with the questions \"The app helped me discuss my asthma with my healthcare providers during my most recent visit?\", \"App helped the appointment with my doctor go more smoothly?\" and \"I was included in making decisions about my asthma treatment during my most recent visit?\" on the participant visit experience survey.", "timeFrame": "End of Study (Month 6)"}, {"measure": "Patient Satisfaction Questionnaire-18 Subscale Scores (End of Study)", "description": "Participant satisfaction with their healthcare experience was evaluated using the PSQ-18 items with subscale scores of 'General satisfaction, Technical quality, Interpersonal manner, Communication, Financial aspects, Time spent with doctor, Accessibility and convenience' at End of Study (Month 6). The PSQ-18 scores ranges from 1 to 5 and a higher score indicates greater satisfaction.", "timeFrame": "End of study (Month 6)"}, {"measure": "Patient-Reported System Usability Scale (SUS) (Month 1)", "description": "The usability of the AMAZE\u2122 App was measured by the number of participants who rated the app as 'excellent, good, okay, poor, awful or skipped to report' at Month 1.", "timeFrame": "Month 1"}, {"measure": "Patient-Reported SUS (End of Study)", "description": "The usability of the AMAZE\u2122 App was measured by the number of participants who rated the app as 'excellent, good, okay, poor, awful or skipped to report' at End of Study (Month 6).", "timeFrame": "End of Study (Month 6)"}, {"measure": "Clinical Site Staff-Reported SUS (Month 1)", "description": "The usability of the AMAZE\u2122 dashboard was measured by the number of clinical staff who rated the App as 'excellent, good, okay, poor, awful or skipped to report' at Month 1.", "timeFrame": "Month 1"}, {"measure": "Clinical Site Staff-Reported SUS (End of Study)", "description": "The usability of the AMAZE\u2122 dashboard was measured by the number of clinical staff who rated the App as 'excellent, good, okay, poor, awful or skipped to report' at End of Study (Month 6).", "timeFrame": "End of Study (Month 6)"}, {"measure": "Evaluate Ease of Implementation of AMAZE\u2122 App in Clinical Setting (End of Study)", "description": "The ease of implementation of AMAZE\u2122 was measured by the number of clinical staff who reported \"very easy\" or \"somewhat easy\" to the question \"How would you rate the overall ease of implementing AMAZE\u2122 on a platform into your clinical practice?\" in the post-study survey at End of Study (Month 6).", "timeFrame": "End of Study (Month 6)"}, {"measure": "Evaluate Impact of AMAZE\u2122 App on Managing Participants (End of Study)", "description": "The impact of AMAZE\u2122 on managing participants was measured by the number of clinical staff who reported \"moderately\" or \"very well\" to the question \"Did the AMAZE\u2122 help you manage your participants?\" in the post-study survey at End of Study (Month 6).", "timeFrame": "End of Study (Month 6)"}, {"measure": "Evaluate Perceived Benefit of AMAZE\u2122 App in Clinical Setting (End of Study)", "description": "The perceived benefit of AMAZE\u2122 was evaluated by the number of clinical staff who endorsed different perceived benefits as \"Ability to track symptoms, Ability to track asthma triggers, Ability to track reliever medication use, Ability track ER visits/ hospitalizations, and Integration of AMAZE\u2122 platform with electronic health records\" based on the item \"What did you find the most useful about the AMAZE\u2122 platform?\" in the post-study survey at End of Study (Month 6).", "timeFrame": "End of Study (Month 6)"}, {"measure": "Evaluate Perceived Disadvantages of AMAZE\u2122 in Clinical Setting (End of Study)", "description": "The perceived disadvantages of AMAZE\u2122 were evaluated by the number of clinical site staff who endorsed different perceived disadvantages as \"Ability to track air flow measurements, Participant-health care provides (HCP) messaging feature, Ability to assign another healthcare provider to a participant, Ability to track level of impairment through Asthma Control Test (ACT\u2122) scores\" based on the question \"What did you find the least useful or cumbersome about the AMAZE\u2122 platform?\" in the post-study survey at End of Study (Month 6).", "timeFrame": "End of Study (Month 6)."}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* \\>18 years of age at the time of enrollment\n* Clinically confirmed diagnosis of asthma\n* Access to a smartphone with internet access with the following requirements: iOS (Operating System iOS 13 or newer and Devices iPhone 8 or newer) or Android (Operating System 8.0 or newer)\n* Able to understand and speak English sufficiently to be able to use the AMAZE\u2122 patient app\n* Willingness to participate in a telephone interview and be audio-recorded\n* Consenting to participate in the study\n\nExclusion Criteria:\n\n* Current diagnosis of active chronic obstructive pulmonary disease (COPD) or any pulmonary diagnosis other than asthma\n* Has a cognitive impairment, hearing difficulty, acute psychopathology, medical condition, or insufficient knowledge of the English language that, in the opinion of the investigator, would interfere with his or her ability to agree to participate and/or complete the ACT\u2122.", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"locations": [{"facility": "Research Site", "city": "Boston", "state": "Massachusetts", "zip": "02114", "country": "United States", "geoPoint": {"lat": 42.35843, "lon": -71.05977}}]}, "referencesModule": {"seeAlsoLinks": [{"label": "Related Info", "url": "https://filehosting-v2.pharmacm.com/api/Attachment/Download?tenantId=80217111&amp;parentIdentifier=N4280000000&amp;attachmentIdentifier=68577816-6a4e-44ca-9d9d-5cc363bbd99f&amp;fileName=EVA-28838_AMAZE_Redacted_Synopsis_20July2022_Clean_V2-v1.pdf&amp;versionIdentifier="}, {"label": "Related Info", "url": "https://filehosting-v2.pharmacm.com/api/Attachment/Download?tenantId=80217111&amp;parentIdentifier=N4280000000&amp;attachmentIdentifier=1bde190a-9f41-4102-af15-b25bdbb9b4d7&amp;fileName=1_clean_Asthma_Sponsor_Protocol_AZPulm_2021Aug10-Redacted.pdf&amp;versionIdentifier="}, {"label": "Related Info", "url": "https://filehosting-v2.pharmacm.com/api/Attachment/Download?tenantId=80217111&amp;parentIdentifier=N4280000000&amp;attachmentIdentifier=f209dddf-4104-405b-983f-7c7e39d6d2ef&amp;fileName=EVA-28838_AMAZE_DMP_SAP_v5.0_27July2021_FINAL-Redacted.pdf&amp;versionIdentifier="}]}, "ipdSharingStatementModule": {"ipdSharing": "YES", "description": "Qualified researchers can request access to anonymized individual patient-level data from AstraZeneca group of companies sponsored clinical trials via the request portal. All request will be evaluated as per the AZ disclosure commitment: https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure.\n\nYes, indicates that AZ are accepting requests for IPD, but this does not mean all requests will be shared.", "infoTypes": ["STUDY_PROTOCOL", "SAP"], "timeFrame": "AstraZeneca will meet or exceed data availability as per the commitments made to the EFPIA Pharma Data Sharing Principles. For details of our timelines, please rerefer to our disclosure commitment at https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure.", "accessCriteria": "When a request has been approved AstraZeneca will provide access to the deidentified individual patient-level data in an approved sponsored tool . Signed Data Sharing Agreement (non-negotiable contract for data accessors) must be in place before accessing requested information. Additionally, all users will need to accept the terms and conditions of the SAS MSE to gain access. For additional details, please review the Disclosure Statements at https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure.", "url": "https://astrazenecagroup-dt.pharmacm.com/DT/Home"}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "Massachusetts General Hospital (MGH) Participants", "description": "Participants used the AMAZE\u2122 application to enter daily asthma symptoms and impact to communicate this information to their healthcare provider, as well as access disease educational materials up to six months."}, {"id": "FG001", "title": "Massachusetts General Hospital (MGH) Clinical Site Staff", "description": "Clinical site staff used the AMAZE\u2122 dashboard for six months to identify usability and barriers, benefits, challenges, ease of implementation, and areas for improvement of the AMAZE\u2122 dashboard in a clinical setting."}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "42"}, {"groupId": "FG001", "numSubjects": "7"}]}, {"type": "Not Started", "comment": "Participants and Clinical Site Staff who terminated early due to clinician's decision and who never opened the Application (App)", "achievements": [{"groupId": "FG000", "numSubjects": "4"}, {"groupId": "FG001", "numSubjects": "1"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "38"}, {"groupId": "FG001", "numSubjects": "6"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "4"}, {"groupId": "FG001", "numSubjects": "1"}]}], "dropWithdraws": [{"type": "Participants and Clinical Site Staff terminated early", "reasons": [{"groupId": "FG000", "numSubjects": "3"}, {"groupId": "FG001", "numSubjects": "1"}]}, {"type": "Participants and Clinical Site Staff never opened App", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"populationDescription": "All eligible participants who successfully enrolled in the implementation study were analyzed.", "groups": [{"id": "BG000", "title": "Massachusetts General Hospital (MGH) Participants", "description": "Participants used the AMAZE\u2122 application to enter daily asthma symptoms and impact to communicate this information to their healthcare provider, as well as access disease educational materials up to six months."}, {"id": "BG001", "title": "Massachusetts General Hospital (MGH) Clinical Site Staff", "description": "Clinical site staff used the AMAZE\u2122 dashboard for six months to identify usability and barriers, benefits, challenges, ease of implementation, and areas for improvement of the AMAZE\u2122 dashboard in a clinical setting."}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "38"}, {"groupId": "BG001", "value": "6"}, {"groupId": "BG002", "value": "44"}]}], "measures": [{"title": "Age, Continuous", "description": "Not recorded for MGH Clinical Site Staff.", "populationDescription": "Data only collected for MGH Participants arm for this baseline measure.", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "Years", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "38"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "38"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "24.5", "spread": "12.0"}, {"groupId": "BG002", "value": "24.5", "spread": "12.0"}]}]}]}, {"title": "Sex: Female, Male", "description": "Not recorded for MGH Clinical Site Staff.", "populationDescription": "Data only collected for MGH Participants arm for this baseline measure.", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "38"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "38"}]}], "categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "26"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "26"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "12"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "12"}]}]}]}, {"title": "Ethnicity (NIH/OMB)", "description": "Not recorded for MGH Clinical Site Staff.", "populationDescription": "Data only collected for MGH Participants arm for this baseline measure.", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "38"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "38"}]}], "categories": [{"title": "Hispanic or Latino", "measurements": [{"groupId": "BG000", "value": "7"}, {"groupId": "BG002", "value": "7"}]}, {"title": "Not Hispanic or Latino", "measurements": [{"groupId": "BG000", "value": "30"}, {"groupId": "BG002", "value": "30"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "1"}, {"groupId": "BG002", "value": "1"}]}]}]}, {"title": "Race (NIH/OMB)", "description": "Not recorded for MGH Clinical Site Staff.", "populationDescription": "Data only collected for MGH Participants arm for this baseline measure.", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "38"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "38"}]}], "categories": [{"title": "American Indian or Alaska Native", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Asian", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Native Hawaiian or Other Pacific Islander", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Black or African American", "measurements": [{"groupId": "BG000", "value": "2"}, {"groupId": "BG002", "value": "2"}]}, {"title": "White", "measurements": [{"groupId": "BG000", "value": "33"}, {"groupId": "BG002", "value": "33"}]}, {"title": "More than one race", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "3"}, {"groupId": "BG002", "value": "3"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Number of Days Participants Accessed the AMAZE\u2122 App (Weeks 1 to 4)", "description": "Participant App usage was measured as the number of days the participant engaged (ie., participants accessed 'Home, Daily asthma log, Air quality, My plan, Trends, Appointments, Educational material, Messages, and Notifications') with the App during Weeks 1 to 4.", "populationDescription": "All eligible participants successfully enrolled in the implementation study were analyzed. Here, 'Number of Participants Analyzed' denotes number of participants who accessed the App for the specified time frame and 'Number Analyzed' denotes number of participants analyzed for the specified parameter.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Days", "timeFrame": "Weeks 1 to 4", "groups": [{"id": "OG000", "title": "Massachusetts General Hospital (MGH) Participants", "description": "Participants used the AMAZE\u2122 application to enter daily asthma symptoms and impact to communicate this information to their healthcare provider, as well as access disease educational materials up to six months."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "36"}]}], "classes": [{"title": "Home", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "36"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "16.8", "spread": "7.1"}]}]}, {"title": "Daily asthma log", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "36"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "16.5", "spread": "6.8"}]}]}, {"title": "Air quality", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "11"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "2.3", "spread": "1.5"}]}]}, {"title": "My plan", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "30"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "2.2", "spread": "1.5"}]}]}, {"title": "Trends", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "26"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "2.8", "spread": "3.0"}]}]}, {"title": "Appointments", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "4"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.3", "spread": "0.5"}]}]}, {"title": "Educational material", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "3"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.0", "spread": "0.0"}]}]}, {"title": "Messages", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "26"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "2.3", "spread": "2.4"}]}]}, {"title": "Notifications", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "35"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.3", "spread": "0.5"}]}]}]}, {"type": "PRIMARY", "title": "Number of Days Participants Accessed the AMAZE\u2122 App (Weeks 5 to 8)", "description": "Participant App usage was measured as the number of days the participant engaged (ie., participants accessed 'Home, Daily asthma log, Air quality, My plan, Trends, Appointments, Educational material, Messages, and Notifications') with the App during Weeks 5 to 8.", "populationDescription": "All eligible participants successfully enrolled in the implementation study were analyzed. Here, 'Number of Participants Analyzed' denotes number of participants who accessed the App for the specified time frame and 'Number Analyzed' denotes number of participants analyzed for the specified parameter.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Days", "timeFrame": "Weeks 5 to 8", "groups": [{"id": "OG000", "title": "Massachusetts General Hospital (MGH) Participants", "description": "Participants used the AMAZE\u2122 application to enter daily asthma symptoms and impact to communicate this information to their healthcare provider, as well as access disease educational materials up to six months."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "33"}]}], "classes": [{"title": "Home", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "33"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "12.5", "spread": "8.6"}]}]}, {"title": "Daily asthma log", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "33"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "12.1", "spread": "8.6"}]}]}, {"title": "Air quality", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "2"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.5", "spread": "0.7"}]}]}, {"title": "My plan", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "15"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.6", "spread": "0.8"}]}]}, {"title": "Trends", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "16"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.6", "spread": "0.8"}]}]}, {"title": "Appointments", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "4"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.3", "spread": "0.5"}]}]}, {"title": "Educational material", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "2"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.0", "spread": "0.0"}]}]}, {"title": "Messages", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "13"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.8", "spread": "1.5"}]}]}, {"title": "Notifications", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "2"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.0", "spread": "0.0"}]}]}]}, {"type": "PRIMARY", "title": "Number of Days Participants Accessed the AMAZE\u2122 App (Weeks 9 to 12)", "description": "Participant App usage was measured as the number of days the participant engaged (ie., participants accessed 'Home, Daily asthma log, Air quality, My plan, Trends, Appointments, Educational material, Messages, and Notifications') with the App during Weeks 9 to 12.", "populationDescription": "All eligible participants successfully enrolled in the implementation study were analyzed. Here, 'Number of Participants Analyzed' denotes number of participants who accessed the App for the specified time frame and 'Number Analyzed' denotes number of participants analyzed for the specified parameter.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Days", "timeFrame": "Weeks 9 to 12", "groups": [{"id": "OG000", "title": "Massachusetts General Hospital (MGH) Participants", "description": "Participants used the AMAZE\u2122 application to enter daily asthma symptoms and impact to communicate this information to their healthcare provider, as well as access disease educational materials up to six months."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "30"}]}], "classes": [{"title": "Home", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "30"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "11.4", "spread": "8.1"}]}]}, {"title": "Daily asthma log", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "29"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "11.2", "spread": "7.8"}]}]}, {"title": "Air quality", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "2"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.0", "spread": "0.0"}]}]}, {"title": "My plan", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "11"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.5", "spread": "1.0"}]}]}, {"title": "Trends", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "9"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.4", "spread": "0.5"}]}]}, {"title": "Appointments", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "3"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.3", "spread": "0.6"}]}]}, {"title": "Educational material", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.0", "spread": "NA", "comment": "Standard deviation was not reported as only one participant was evaluable for the specified arm group."}]}]}, {"title": "Messages", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "13"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.4", "spread": "0.5"}]}]}, {"title": "Notifications", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "4"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.0", "spread": "0.0"}]}]}]}, {"type": "PRIMARY", "title": "Number of Days Participants Accessed the AMAZE\u2122 App (Weeks 13 to 16)", "description": "Participant App usage was measured as the number of days the participant engaged (ie., participants accessed 'Home, Daily asthma log, Air quality, My plan, Trends, Appointments, Educational material, Messages, and Notifications') with the App during Weeks 13 to 16.", "populationDescription": "All eligible participants successfully enrolled in the implementation study were analyzed. Here, 'Number of Participants Analyzed' denotes number of participants who accessed the App for the specified time frame and 'Number Analyzed' denotes number of participants analyzed for the specified parameter.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Days", "timeFrame": "Weeks 13 to 16", "groups": [{"id": "OG000", "title": "Massachusetts General Hospital (MGH) Participants", "description": "Participants used the AMAZE\u2122 application to enter daily asthma symptoms and impact to communicate this information to their healthcare provider, as well as access disease educational materials up to six months."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "25"}]}], "classes": [{"title": "Home", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "25"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "12.6", "spread": "8.2"}]}]}, {"title": "Daily asthma log", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "25"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "12.1", "spread": "8.1"}]}]}, {"title": "Air quality", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "3"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.0", "spread": "0.0"}]}]}, {"title": "My plan", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "10"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.1", "spread": "0.3"}]}]}, {"title": "Trends", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "12"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.1", "spread": "0.3"}]}]}, {"title": "Appointments", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "5"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.2", "spread": "0.4"}]}]}, {"title": "Educational material", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "3"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.0", "spread": "0.0"}]}]}, {"title": "Messages", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "12"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.3", "spread": "0.6"}]}]}, {"title": "Notifications", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "2"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.0", "spread": "0.0"}]}]}]}, {"type": "PRIMARY", "title": "Number of Days Participants Accessed the AMAZE\u2122 App (Weeks 17 to 20)", "description": "Participant App usage was measured as the number of days the participant engaged (ie., participants accessed 'Home, Daily asthma log, Air quality, My plan, Trends, Appointments, Educational material, Messages, and Notifications') with the App during Weeks 17 to 20.", "populationDescription": "All eligible participants successfully enrolled in the implementation study were analyzed. Here, 'Number of Participants Analyzed' denotes number of participants who accessed the App for the specified time frame and 'Number Analyzed' denotes number of participants analyzed for the specified parameter.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Days", "timeFrame": "Weeks 17 to 20", "groups": [{"id": "OG000", "title": "Massachusetts General Hospital (MGH) Participants", "description": "Participants used the AMAZE\u2122 application to enter daily asthma symptoms and impact to communicate this information to their healthcare provider, as well as access disease educational materials up to six months."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "22"}]}], "classes": [{"title": "Home", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "22"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "9.3", "spread": "7.5"}]}]}, {"title": "Daily asthma log", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "22"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "8.9", "spread": "7.2"}]}]}, {"title": "Air quality", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.0", "spread": "NA", "comment": "Standard deviation was not reported as only one participant was evaluable for the specified arm group."}]}]}, {"title": "My plan", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "5"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.2", "spread": "0.4"}]}]}, {"title": "Trends", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "6"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.2", "spread": "0.4"}]}]}, {"title": "Appointments", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "2"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.5", "spread": "0.7"}]}]}, {"title": "Educational material", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.0", "spread": "NA", "comment": "Standard deviation was not reported as only one participant was evaluable for the specified arm group."}]}]}, {"title": "Messages", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "6"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.3", "spread": "0.8"}]}]}, {"title": "Notifications", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "3"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.0", "spread": "0.0"}]}]}]}, {"type": "PRIMARY", "title": "Number of Days Participants Accessed the AMAZE\u2122 App (Weeks 21 to 24)", "description": "Participant App usage was measured as the number of days the participant engaged (ie., participants accessed 'Home, Daily asthma log, Air quality, My plan, Trends, Appointments, Educational material, Messages, and Notifications') with the App during Weeks 21 to 24.", "populationDescription": "All eligible participants successfully enrolled in the implementation study were analyzed. Here, 'Number of Participants Analyzed' denotes number of participants who accessed the App for the specified time frame and 'Number Analyzed' denotes number of participants analyzed for the specified parameter.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Days", "timeFrame": "Weeks 21 to 24", "groups": [{"id": "OG000", "title": "Massachusetts General Hospital (MGH) Participants", "description": "Participants used the AMAZE\u2122 application to enter daily asthma symptoms and impact to communicate this information to their healthcare provider, as well as access disease educational materials up to six months."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "14"}]}], "classes": [{"title": "Home", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "14"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "7.6", "spread": "7.2"}]}]}, {"title": "Daily asthma log", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "13"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "7.8", "spread": "7.3"}]}]}, {"title": "Air quality", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "My plan", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "5"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.2", "spread": "0.4"}]}]}, {"title": "Trends", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "3"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.0", "spread": "0.0"}]}]}, {"title": "Appointments", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "3.0", "spread": "NA", "comment": "Standard deviation was not reported as only one participant was evaluable for the specified arm group."}]}]}, {"title": "Educational material", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "Messages", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "4"}]}], "categories": [{"measurements": [{"groupId": "OG000", "value": "1.3", "spread": "0.5"}]}]}, {"title": "Notifications", "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "0"}]}]}]}, {"type": "PRIMARY", "title": "Number of Days Clinical Site Staff Accessed the AMAZE\u2122 Dashboard (Weeks 1 to 4)", "description": "Clinician dashboard usage was measured as the mean number of days that the clinical site staff accessed the AMAZE\u2122 dashboard during Weeks 1 to 4.", "populationDescription": "Clinical site staff who used the AMAZE\u2122 dashboard at the specified time frame were considered for this outcome measure.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Days", "timeFrame": "Weeks 1 to 4", "groups": [{"id": "OG000", "title": "Massachusetts General Hospital (MGH) Clinical Site Staff", "description": "Clinical site staff used the AMAZE\u2122 dashboard for six months to identify usability and barriers, benefits, challenges, ease of implementation, and areas for improvement of the AMAZE\u2122 dashboard in a clinical setting."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "3"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "8.3", "spread": "6.7"}]}]}]}, {"type": "PRIMARY", "title": "Number of Days Clinical Site Staff Accessed the AMAZE\u2122 Dashboard (Weeks 5 to 8)", "description": "Clinician dashboard usage was measured as the mean number of days that the clinical site staff accessed the AMAZE\u2122 dashboard during Weeks 5 to 8.", "populationDescription": "Clinical site staff who used the AMAZE\u2122 dashboard at the specified time frame were considered for this outcome measure.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Days", "timeFrame": "Weeks 5 to 8", "groups": [{"id": "OG000", "title": "Massachusetts General Hospital (MGH) Clinical Site Staff", "description": "Clinical site staff used the AMAZE\u2122 dashboard for six months to identify usability and barriers, benefits, challenges, ease of implementation, and areas for improvement of the AMAZE\u2122 dashboard in a clinical setting."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "5"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "5.8", "spread": "6.1"}]}]}]}, {"type": "PRIMARY", "title": "Number of Days Clinical Site Staff Accessed the AMAZE\u2122 Dashboard (Weeks 9 to 12)", "description": "Clinician dashboard usage was measured as the mean number of days that the clinical site staff accessed the AMAZE\u2122 dashboard during Weeks 9 to 12.", "populationDescription": "Clinical site staff who used the AMAZE\u2122 dashboard at the specified time frame were considered for this outcome measure.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Days", "timeFrame": "Weeks 9 to 12", "groups": [{"id": "OG000", "title": "Massachusetts General Hospital (MGH) Clinical Site Staff", "description": "Clinical site staff used the AMAZE\u2122 dashboard for six months to identify usability and barriers, benefits, challenges, ease of implementation, and areas for improvement of the AMAZE\u2122 dashboard in a clinical setting."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "5"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "6.6", "spread": "6.1"}]}]}]}, {"type": "PRIMARY", "title": "Number of Days Clinical Site Staff Accessed the AMAZE\u2122 Dashboard (Weeks 13 to 16)", "description": "Clinician dashboard usage was measured as the mean number of days that the clinical site staff accessed the AMAZE\u2122 dashboard during Weeks 13 to 16.", "populationDescription": "Clinical site staff who used the AMAZE\u2122 dashboard at the specified time frame were considered for this outcome measure.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Days", "timeFrame": "Weeks 13 to 16", "groups": [{"id": "OG000", "title": "Massachusetts General Hospital (MGH) Clinical Site Staff", "description": "Clinical site staff used the AMAZE\u2122 dashboard for six months to identify usability and barriers, benefits, challenges, ease of implementation, and areas for improvement of the AMAZE\u2122 dashboard in a clinical setting."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "6"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "5.8", "spread": "6.5"}]}]}]}, {"type": "PRIMARY", "title": "Number of Days Clinical Site Staff Accessed the AMAZE\u2122 Dashboard (Weeks 17 to 20)", "description": "Clinician dashboard usage was measured as the mean number of days that the clinical site staff accessed the AMAZE\u2122 dashboard during Weeks 17 to 20.", "populationDescription": "Clinical site staff who used the AMAZE\u2122 dashboard at the specified time frame were considered for this outcome measure.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Days", "timeFrame": "Weeks 17 to 20", "groups": [{"id": "OG000", "title": "Massachusetts General Hospital (MGH) Clinical Site Staff", "description": "Clinical site staff used the AMAZE\u2122 dashboard for six months to identify usability and barriers, benefits, challenges, ease of implementation, and areas for improvement of the AMAZE\u2122 dashboard in a clinical setting."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "5"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "5.6", "spread": "6.5"}]}]}]}, {"type": "PRIMARY", "title": "Number of Days Clinical Site Staff Accessed the AMAZE\u2122 Dashboard (Weeks 21 to 24)", "description": "Clinician dashboard usage was measured as the mean number of days that the clinical site staff accessed the AMAZE\u2122 dashboard during Weeks 21 to 24.", "populationDescription": "Clinical site staff who used the AMAZE\u2122 dashboard at the specified time frame were considered for this outcome measure.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Days", "timeFrame": "Weeks 21 to 24", "groups": [{"id": "OG000", "title": "Massachusetts General Hospital (MGH) Clinical Site Staff", "description": "Clinical site staff used the AMAZE\u2122 dashboard for six months to identify usability and barriers, benefits, challenges, ease of implementation, and areas for improvement of the AMAZE\u2122 dashboard in a clinical setting."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "3"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "6.7", "spread": "4.9"}]}]}]}, {"type": "PRIMARY", "title": "Number of Participants Engaged in Agreement of Visit Survey Item 9 (Weeks 1 to 4)", "description": "Visit Survey Item 9 was 'The visit helped avoid an emergency room (ER) or urgent care center visit or hospitalization.' Visit surveys were completed throughout the study whenever a participant completed an asthma-related clinic visit. Number of participants engaged in agreement of Visit Survey Item 9 as 'High' (ie., 5-7 days per week per month) and 'Very low' (ie., less than one day per week per month) are reported.", "populationDescription": "All eligible participants successfully enrolled in the implementation study were analyzed. Here, 'Number of Participants Analyzed' denotes number of participants analyzed for the specified time frame.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Weeks 1 to 4", "groups": [{"id": "OG000", "title": "Massachusetts General Hospital (MGH) Participants", "description": "Participants used the AMAZE\u2122 application to enter daily asthma symptoms and impact to communicate this information to their healthcare provider, as well as access disease educational materials up to six months."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1"}]}], "classes": [{"title": "High", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}]}]}, {"title": "Very low", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}]}, {"type": "PRIMARY", "title": "Number of Participants Engaged in Agreement of Visit Survey Item 9 (Weeks 5 to 8)", "description": "Visit Survey Item 9 was 'The visit helped avoid an ER or urgent care center visit or hospitalization.' Visit surveys were completed throughout the study whenever a participant completed an asthma-related clinic visit. Number of participants engaged in agreement of Visit Survey Item 9 as 'High' (ie., 5-7 days per week per month) and 'Very low' (ie., less than one day per week per month) are reported.", "populationDescription": "All eligible participants successfully enrolled in the implementation study were analyzed. Here, 'Number of Participants Analyzed' denotes number of participants analyzed for the specified time frame.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Weeks 5 to 8", "groups": [{"id": "OG000", "title": "Massachusetts General Hospital (MGH) Participants", "description": "Participants used the AMAZE\u2122 application to enter daily asthma symptoms and impact to communicate this information to their healthcare provider, as well as access disease educational materials up to six months."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1"}]}], "classes": [{"title": "High", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}]}]}, {"title": "Very low", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}]}, {"type": "PRIMARY", "title": "Number of Participants Engaged in Agreement of Visit Survey Item 9 (Weeks 9 to 12)", "description": "Visit Survey Item 9 was 'The visit helped avoid an ER or urgent care center visit or hospitalization.' Visit surveys were completed throughout the study whenever a participant completed an asthma-related clinic visit. Number of participants engaged in agreement of Visit Survey Item 9 as 'High' (ie., 5-7 days per week per month) and 'Very low' (ie., less than one day per week per month) are reported.", "populationDescription": "All eligible participants successfully enrolled in the implementation study were analyzed. Here, 'Number of Participants Analyzed' denotes number of participants analyzed for the specified time frame.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Weeks 9 to 12", "groups": [{"id": "OG000", "title": "Massachusetts General Hospital (MGH) Participants", "description": "Participants used the AMAZE\u2122 application to enter daily asthma symptoms and impact to communicate this information to their healthcare provider, as well as access disease educational materials up to six months."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1"}]}], "classes": [{"title": "High", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}]}]}, {"title": "Very low", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}]}, {"type": "PRIMARY", "title": "Number of Participants Engaged in Agreement of Visit Survey Item 9 (Weeks 13 to 16)", "description": "Visit Survey Item 9 was 'The visit helped avoid an ER or urgent care center visit or hospitalization.' Visit surveys were completed throughout the study whenever a participant completed an asthma-related clinic visit. Number of participants engaged in agreement of Visit Survey Item 9 as 'High' (ie., 5-7 days per week per month) and 'Very low' (ie., less than one day per week per month) are reported.", "populationDescription": "All eligible participants successfully enrolled in the implementation study were analyzed. Here, 'Number of Participants Analyzed' denotes number of participants analyzed for the specified time frame.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Weeks 13 to 16", "groups": [{"id": "OG000", "title": "Massachusetts General Hospital (MGH) Participants", "description": "Participants used the AMAZE\u2122 application to enter daily asthma symptoms and impact to communicate this information to their healthcare provider, as well as access disease educational materials up to six months."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1"}]}], "classes": [{"title": "High", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}]}]}, {"title": "Very low", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}]}, {"type": "PRIMARY", "title": "Number of Participants Engaged in Agreement of Visit Survey Item 9 (Weeks 17 to 20)", "description": "Visit Survey Item 9 was 'The visit helped avoid an ER or urgent care center visit or hospitalization.' Visit surveys were completed throughout the study whenever a participant completed an asthma-related clinic visit. Number of participants engaged in agreement of Visit Survey Item 9 as 'High' (ie., 5-7 days per week per month) and 'Very low' (ie., less than one day per week per month) are reported.", "populationDescription": "All eligible participants successfully enrolled in the implementation study were analyzed. Here, 'Number of Participants Analyzed' denotes number of participants analyzed for the specified time frame.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Weeks 17 to 20", "groups": [{"id": "OG000", "title": "Massachusetts General Hospital (MGH) Participants", "description": "Participants used the AMAZE\u2122 application to enter daily asthma symptoms and impact to communicate this information to their healthcare provider, as well as access disease educational materials up to six months."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1"}]}], "classes": [{"title": "High", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "Very low", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}]}]}]}, {"type": "PRIMARY", "title": "Number of Participants Engaged in Agreement of Visit Survey Item 9 (Weeks 21 to 24)", "description": "Visit Survey Item 9 was 'The visit helped avoid an ER or urgent care center visit or hospitalization.' Visit surveys were completed throughout the study whenever a participant completed an asthma-related clinic visit. Number of participants engaged in agreement of Visit Survey Item 9 as 'High' (ie., 5-7 days per week per month) and 'Very low' (ie., less than one day per week per month) are reported.", "populationDescription": "No participant completed at least one daily asthma log during the specified time frame (Weeks 21 to 24), so no data was reported.", "reportingStatus": "POSTED", "timeFrame": "Weeks 21 to 24", "groups": [{"id": "OG000", "title": "Massachusetts General Hospital (MGH) Participants", "description": "Participants used the AMAZE\u2122 application to enter daily asthma symptoms and impact to communicate this information to their healthcare provider, as well as access disease educational materials up to six months."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "0"}]}]}, {"type": "PRIMARY", "title": "Evaluate Participant Satisfaction With the AMAZE\u2122 App (End of Study)", "description": "Satisfaction with the AMAZE\u2122 App features was measured by the number of participants who reported satisfaction on parameters of 'Very unsatisfied, Unsatisfied, Neutral, Satisfied, and Very satisfied'.", "populationDescription": "All eligible participants successfully enrolled in the implementation study were analyzed. Here, 'Number of Participants Analyzed' denotes number of participants analyzed at Month 6.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "End of Study (Month 6)", "groups": [{"id": "OG000", "title": "Massachusetts General Hospital (MGH) Participants", "description": "Participants used the AMAZE\u2122 application to enter daily asthma symptoms and impact to communicate this information to their healthcare provider, as well as access disease educational materials up to six months."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "22"}]}], "classes": [{"title": "Very unsatisfied", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}]}]}, {"title": "Unsatisfied", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "Neutral", "categories": [{"measurements": [{"groupId": "OG000", "value": "3"}]}]}, {"title": "Satisfied", "categories": [{"measurements": [{"groupId": "OG000", "value": "12"}]}]}, {"title": "Very satisfied", "categories": [{"measurements": [{"groupId": "OG000", "value": "6"}]}]}]}, {"type": "PRIMARY", "title": "Emergency Room Visits, Urgent Care Center Visits, or Hospitalization Avoidance (End of Study)", "description": "The impact of AMAZE\u2122 on ER, urgent care center visits, and hospitalizations was measured as the number of participants who reported \"agree\" or \"strongly agree\" with the question 'Since the start of the study, use of the AMAZE\u2122 App helped me avoid ER or urgent care center visits or hospitalizations.' from the participant visit experience survey.", "populationDescription": "All eligible participants successfully enrolled in the implementation study were analyzed. Here, 'Number of Participants Analyzed' denotes number of participants analyzed at Month 6.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "End of Study (Month 6)", "groups": [{"id": "OG000", "title": "Massachusetts General Hospital (MGH) Participants", "description": "Participants used the AMAZE\u2122 application to enter daily asthma symptoms and impact to communicate this information to their healthcare provider, as well as access disease educational materials up to six months."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "22"}]}], "classes": [{"title": "Strongly agree", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}]}]}, {"title": "Agree", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}]}]}]}, {"type": "PRIMARY", "title": "Impact of AMAZE\u2122 App on Participants Clinic Visits", "description": "Visit Survey Item 9 was 'The visit helped avoid an ER or urgent care center visit or hospitalization.' The impact of AMAZE\u2122 on participant visits was measured as the number of participants who selected \"agree\" or \"strongly agree\" in response to the 9-items in the participant visit experience survey.", "populationDescription": "All eligible participants successfully enrolled in the implementation study were analyzed. Here, 'Number of Participants Analyzed' denotes number of participants analyzed for the specified time frame.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Day 1 through End of Study (Month 6)", "groups": [{"id": "OG000", "title": "Massachusetts General Hospital (MGH) Participants", "description": "Participants used the AMAZE\u2122 application to enter daily asthma symptoms and impact to communicate this information to their healthcare provider, as well as access disease educational materials up to six months."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "20"}]}], "classes": [{"title": "Strongly agree", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}]}]}, {"title": "Agree", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}]}, {"type": "PRIMARY", "title": "Participant Perception of Appointment Discussions and Taking Part in Asthma Decisions (End of Study)", "description": "The impact of AMAZE\u2122 on improved participant communication with their healthcare provider was measured as the number of participants who reported \"agree\" or \"strongly agree\" with the questions \"The app helped me discuss my asthma with my healthcare providers during my most recent visit?\", \"App helped the appointment with my doctor go more smoothly?\" and \"I was included in making decisions about my asthma treatment during my most recent visit?\" on the participant visit experience survey.", "populationDescription": "All eligible participants successfully enrolled in the implementation study were analyzed. Here, 'Number of Participants Analyzed' denotes number of participants analyzed at Month 6.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "End of Study (Month 6)", "groups": [{"id": "OG000", "title": "Massachusetts General Hospital (MGH) Participants", "description": "Participants used the AMAZE\u2122 application to enter daily asthma symptoms and impact to communicate this information to their healthcare provider, as well as access disease educational materials up to six months."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "20"}]}], "classes": [{"title": "Asthma discussions-Strongly Agree", "categories": [{"measurements": [{"groupId": "OG000", "value": "3"}]}]}, {"title": "Asthma Discussions-Agree", "categories": [{"measurements": [{"groupId": "OG000", "value": "5"}]}]}, {"title": "To take appointment smoothly-Strongly agree", "categories": [{"measurements": [{"groupId": "OG000", "value": "3"}]}]}, {"title": "To take appointment smoothly-Agree", "categories": [{"measurements": [{"groupId": "OG000", "value": "3"}]}]}, {"title": "Asthma treatment decision-Strongly agree", "categories": [{"measurements": [{"groupId": "OG000", "value": "14"}]}]}, {"title": "Asthma treatment decision-Agree", "categories": [{"measurements": [{"groupId": "OG000", "value": "4"}]}]}]}, {"type": "PRIMARY", "title": "Patient Satisfaction Questionnaire-18 Subscale Scores (End of Study)", "description": "Participant satisfaction with their healthcare experience was evaluated using the PSQ-18 items with subscale scores of 'General satisfaction, Technical quality, Interpersonal manner, Communication, Financial aspects, Time spent with doctor, Accessibility and convenience' at End of Study (Month 6). The PSQ-18 scores ranges from 1 to 5 and a higher score indicates greater satisfaction.", "populationDescription": "All eligible participants successfully enrolled in the implementation study were analyzed. Here, 'Number of Participants Analyzed' denotes number of participants analyzed at Month 6.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Scores on a Scale", "timeFrame": "End of study (Month 6)", "groups": [{"id": "OG000", "title": "Massachusetts General Hospital (MGH) Participants", "description": "Participants used the AMAZE\u2122 application to enter daily asthma symptoms and impact to communicate this information to their healthcare provider, as well as access disease educational materials up to six months."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "22"}]}], "classes": [{"title": "General satisfaction", "categories": [{"measurements": [{"groupId": "OG000", "value": "4.1", "spread": "0.86"}]}]}, {"title": "Technical quality", "categories": [{"measurements": [{"groupId": "OG000", "value": "4.3", "spread": "0.61"}]}]}, {"title": "Interpersonal manner", "categories": [{"measurements": [{"groupId": "OG000", "value": "4.3", "spread": "0.57"}]}]}, {"title": "Communication", "categories": [{"measurements": [{"groupId": "OG000", "value": "4.2", "spread": "0.77"}]}]}, {"title": "Financial aspects", "categories": [{"measurements": [{"groupId": "OG000", "value": "4.0", "spread": "0.91"}]}]}, {"title": "Time spent with doctor", "categories": [{"measurements": [{"groupId": "OG000", "value": "3.8", "spread": "0.95"}]}]}, {"title": "Accessibility and convenience", "categories": [{"measurements": [{"groupId": "OG000", "value": "3.6", "spread": "0.89"}]}]}]}, {"type": "PRIMARY", "title": "Patient-Reported System Usability Scale (SUS) (Month 1)", "description": "The usability of the AMAZE\u2122 App was measured by the number of participants who rated the app as 'excellent, good, okay, poor, awful or skipped to report' at Month 1.", "populationDescription": "All eligible participants successfully enrolled in the implementation study were analyzed. Here, 'Number of Participants Analyzed' denotes number of participants analyzed at Month 1.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Month 1", "groups": [{"id": "OG000", "title": "Massachusetts General Hospital (MGH) Participants", "description": "Participants used the AMAZE\u2122 application to enter daily asthma symptoms and impact to communicate this information to their healthcare provider, as well as access disease educational materials up to six months."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "30"}]}], "classes": [{"title": "Excellent", "categories": [{"measurements": [{"groupId": "OG000", "value": "17", "spread": "56.7"}]}]}, {"title": "Good", "categories": [{"measurements": [{"groupId": "OG000", "value": "9", "spread": "30.0"}]}]}, {"title": "Okay", "categories": [{"measurements": [{"groupId": "OG000", "value": "0", "spread": "0.0"}]}]}, {"title": "Poor", "categories": [{"measurements": [{"groupId": "OG000", "value": "3", "spread": "10.0"}]}]}, {"title": "Awful", "categories": [{"measurements": [{"groupId": "OG000", "value": "0", "spread": "0.0"}]}]}, {"title": "Skipped", "categories": [{"measurements": [{"groupId": "OG000", "value": "1", "spread": "3.3"}]}]}]}, {"type": "PRIMARY", "title": "Patient-Reported SUS (End of Study)", "description": "The usability of the AMAZE\u2122 App was measured by the number of participants who rated the app as 'excellent, good, okay, poor, awful or skipped to report' at End of Study (Month 6).", "populationDescription": "All eligible participants successfully enrolled in the implementation study were analyzed. Here, 'Number of Participants Analyzed' denotes number of participants analyzed at Month 6.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "End of Study (Month 6)", "groups": [{"id": "OG000", "title": "Massachusetts General Hospital (MGH) Participants", "description": "Participants used the AMAZE\u2122 application to enter daily asthma symptoms and impact to communicate this information to their healthcare provider, as well as access disease educational materials up to six months."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "22"}]}], "classes": [{"title": "Excellent", "categories": [{"measurements": [{"groupId": "OG000", "value": "14", "spread": "63.6"}]}]}, {"title": "Good", "categories": [{"measurements": [{"groupId": "OG000", "value": "6", "spread": "27.3"}]}]}, {"title": "Okay", "categories": [{"measurements": [{"groupId": "OG000", "value": "0", "spread": "0.0"}]}]}, {"title": "Poor", "categories": [{"measurements": [{"groupId": "OG000", "value": "0", "spread": "0.0"}]}]}, {"title": "Awful", "categories": [{"measurements": [{"groupId": "OG000", "value": "2", "spread": "9.1"}]}]}, {"title": "Skipped", "categories": [{"measurements": [{"groupId": "OG000", "value": "0", "spread": "0.0"}]}]}]}, {"type": "PRIMARY", "title": "Clinical Site Staff-Reported SUS (Month 1)", "description": "The usability of the AMAZE\u2122 dashboard was measured by the number of clinical staff who rated the App as 'excellent, good, okay, poor, awful or skipped to report' at Month 1.", "populationDescription": "Clinical site staff who used the AMAZE\u2122 dashboard at the specified time frame were considered for this outcome measure.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Month 1", "groups": [{"id": "OG000", "title": "Massachusetts General Hospital (MGH) Clinical Site Staff", "description": "Clinical site staff used the AMAZE\u2122 dashboard for six months to identify usability and barriers, benefits, challenges, ease of implementation, and areas for improvement of the AMAZE\u2122 dashboard in a clinical setting."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "5"}]}], "classes": [{"title": "Excellent", "categories": [{"measurements": [{"groupId": "OG000", "value": "0", "spread": "0.0"}]}]}, {"title": "Good", "categories": [{"measurements": [{"groupId": "OG000", "value": "4", "spread": "80.0"}]}]}, {"title": "Okay", "categories": [{"measurements": [{"groupId": "OG000", "value": "0", "spread": "0.0"}]}]}, {"title": "Poor", "categories": [{"measurements": [{"groupId": "OG000", "value": "1", "spread": "20.0"}]}]}, {"title": "Awful", "categories": [{"measurements": [{"groupId": "OG000", "value": "0", "spread": "0.0"}]}]}, {"title": "Skipped", "categories": [{"measurements": [{"groupId": "OG000", "value": "0", "spread": "0.0"}]}]}]}, {"type": "PRIMARY", "title": "Clinical Site Staff-Reported SUS (End of Study)", "description": "The usability of the AMAZE\u2122 dashboard was measured by the number of clinical staff who rated the App as 'excellent, good, okay, poor, awful or skipped to report' at End of Study (Month 6).", "populationDescription": "Clinical site staff who used the AMAZE\u2122 dashboard at the specified time frame were considered for this outcome measure.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "End of Study (Month 6)", "groups": [{"id": "OG000", "title": "Massachusetts General Hospital (MGH) Clinical Site Staff", "description": "Clinical site staff used the AMAZE\u2122 dashboard for six months to identify usability and barriers, benefits, challenges, ease of implementation, and areas for improvement of the AMAZE\u2122 dashboard in a clinical setting."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "4"}]}], "classes": [{"title": "Excellent", "categories": [{"measurements": [{"groupId": "OG000", "value": "1", "spread": "25.0"}]}]}, {"title": "Good", "categories": [{"measurements": [{"groupId": "OG000", "value": "1", "spread": "25.0"}]}]}, {"title": "Okay", "categories": [{"measurements": [{"groupId": "OG000", "value": "0", "spread": "0.0"}]}]}, {"title": "Poor", "categories": [{"measurements": [{"groupId": "OG000", "value": "1", "spread": "25.0"}]}]}, {"title": "Awful", "categories": [{"measurements": [{"groupId": "OG000", "value": "0", "spread": "0.0"}]}]}, {"title": "Skipped", "categories": [{"measurements": [{"groupId": "OG000", "value": "1", "spread": "25.0"}]}]}]}, {"type": "PRIMARY", "title": "Evaluate Ease of Implementation of AMAZE\u2122 App in Clinical Setting (End of Study)", "description": "The ease of implementation of AMAZE\u2122 was measured by the number of clinical staff who reported \"very easy\" or \"somewhat easy\" to the question \"How would you rate the overall ease of implementing AMAZE\u2122 on a platform into your clinical practice?\" in the post-study survey at End of Study (Month 6).", "populationDescription": "Clinical site staff who used the AMAZE\u2122 dashboard at the specified time frame were considered for this outcome measure.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "End of Study (Month 6)", "groups": [{"id": "OG000", "title": "Massachusetts General Hospital (MGH) Clinical Site Staff", "description": "Clinical site staff used the AMAZE\u2122 dashboard for six months to identify usability and barriers, benefits, challenges, ease of implementation, and areas for improvement of the AMAZE\u2122 dashboard in a clinical setting."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "6"}]}], "classes": [{"title": "Very easy", "categories": [{"measurements": [{"groupId": "OG000", "value": "4"}]}]}, {"title": "Somewhat easy", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}]}, {"type": "PRIMARY", "title": "Evaluate Impact of AMAZE\u2122 App on Managing Participants (End of Study)", "description": "The impact of AMAZE\u2122 on managing participants was measured by the number of clinical staff who reported \"moderately\" or \"very well\" to the question \"Did the AMAZE\u2122 help you manage your participants?\" in the post-study survey at End of Study (Month 6).", "populationDescription": "Clinical site staff who used the AMAZE\u2122 dashboard at the specified time frame were considered for this outcome measure.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "End of Study (Month 6)", "groups": [{"id": "OG000", "title": "Massachusetts General Hospital (MGH) Clinical Site Staff", "description": "Clinical site staff used the AMAZE\u2122 dashboard for six months to identify usability and barriers, benefits, challenges, ease of implementation, and areas for improvement of the AMAZE\u2122 dashboard in a clinical setting."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "6"}]}], "classes": [{"title": "Moderately", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}]}]}, {"title": "Very well", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}]}, {"type": "PRIMARY", "title": "Evaluate Perceived Benefit of AMAZE\u2122 App in Clinical Setting (End of Study)", "description": "The perceived benefit of AMAZE\u2122 was evaluated by the number of clinical staff who endorsed different perceived benefits as \"Ability to track symptoms, Ability to track asthma triggers, Ability to track reliever medication use, Ability track ER visits/ hospitalizations, and Integration of AMAZE\u2122 platform with electronic health records\" based on the item \"What did you find the most useful about the AMAZE\u2122 platform?\" in the post-study survey at End of Study (Month 6).", "populationDescription": "Clinical site staff who used the AMAZE\u2122 dashboard at the specified time frame were considered for this outcome measure.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "End of Study (Month 6)", "groups": [{"id": "OG000", "title": "Massachusetts General Hospital (MGH) Clinical Site Staff", "description": "Clinical site staff used the AMAZE\u2122 dashboard for six months to identify usability and barriers, benefits, challenges, ease of implementation, and areas for improvement of the AMAZE\u2122 dashboard in a clinical setting."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "6"}]}], "classes": [{"title": "Ability to track symptoms", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}]}]}, {"title": "Ability to track asthma triggers", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}]}]}, {"title": "Ability to track reliever medication use", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}]}]}, {"title": "Ability track ER visits/ hospitalizations", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}]}]}, {"title": "Integration of AMAZE\u2122 platform with electronic health records", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}]}]}]}, {"type": "PRIMARY", "title": "Evaluate Perceived Disadvantages of AMAZE\u2122 in Clinical Setting (End of Study)", "description": "The perceived disadvantages of AMAZE\u2122 were evaluated by the number of clinical site staff who endorsed different perceived disadvantages as \"Ability to track air flow measurements, Participant-health care provides (HCP) messaging feature, Ability to assign another healthcare provider to a participant, Ability to track level of impairment through Asthma Control Test (ACT\u2122) scores\" based on the question \"What did you find the least useful or cumbersome about the AMAZE\u2122 platform?\" in the post-study survey at End of Study (Month 6).", "populationDescription": "Clinical site staff who used the AMAZE\u2122 dashboard at the specified time frame were considered for this outcome measure.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "End of Study (Month 6).", "groups": [{"id": "OG000", "title": "Massachusetts General Hospital (MGH) Clinical Site Staff", "description": "Clinical site staff used the AMAZE\u2122 dashboard for six months to identify usability and barriers, benefits, challenges, ease of implementation, and areas for improvement of the AMAZE\u2122 dashboard in a clinical setting."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "6"}]}], "classes": [{"title": "Ability to track air flow measurements", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}]}]}, {"title": "Participant-HCP messaging feature", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}]}]}, {"title": "Ability to assign another healthcare provider to a participant", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}]}]}, {"title": "Ability to track level of impairment through ACT\u2122 scores", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "timeFrame": "All-Cause Mortality, Serious, and Other (Not Including Serious) Adverse Events were not monitored/assessed.", "description": "This was an interventional study with no requirements to collect adverse events during the study since enrollment in the study was based on disease diagnosis and did not require the administration of a study drug. All-Cause Mortality, Serious, and Other (Not Including Serious) Adverse Events were not monitored/assessed.", "eventGroups": [{"id": "EG000", "title": "Massachusetts General Hospital (MGH) Participants", "description": "Participants used the AMAZE\u2122 application to enter daily asthma symptoms and impact to communicate this information to their healthcare provider, as well as access disease educational materials up to six months.", "deathsNumAffected": 0, "deathsNumAtRisk": 0, "seriousNumAffected": 0, "seriousNumAtRisk": 0, "otherNumAffected": 0, "otherNumAtRisk": 0}, {"id": "EG001", "title": "Massachusetts General Hospital (MGH) Clinical Site Staff", "description": "Clinical site staff used the AMAZE\u2122 dashboard for six months to identify usability and barriers, benefits, challenges, ease of implementation, and areas for improvement of the AMAZE\u2122 dashboard in a clinical setting.", "deathsNumAffected": 0, "deathsNumAtRisk": 0, "seriousNumAffected": 0, "seriousNumAtRisk": 0, "otherNumAffected": 0, "otherNumAtRisk": 0}]}, "moreInfoModule": {"limitationsAndCaveats": {"description": "This was an interventional study with no requirements to collect adverse events during the study since enrollment in the study was based on disease diagnosis and did not require the administration of a study drug."}, "certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true, "otherDetails": "MedImmune has 60 days to review results communications prior to public release and may delete information that compromises ongoing studies or is considered proprietary. This restriction is not intended to compromise the objective scientific integrity of the manuscript, it being understood that results shall be published regardless of outcome."}, "pointOfContact": {"title": "Global Clinical Lead", "organization": "AstraZeneca Clinical Study Information Center", "email": "information.center@astrazeneca.com", "phone": "+1-877-240-9479"}}}, "documentSection": {"largeDocumentModule": {"largeDocs": [{"typeAbbrev": "Prot", "hasProtocol": true, "hasSap": false, "hasIcf": false, "label": "Study Protocol", "date": "2021-08-10", "uploadDate": "2022-11-29T10:35", "filename": "Prot_000.pdf", "size": 7597174}, {"typeAbbrev": "SAP", "hasProtocol": false, "hasSap": true, "hasIcf": false, "label": "Statistical Analysis Plan", "date": "2021-07-27", "uploadDate": "2022-11-29T10:35", "filename": "SAP_001.pdf", "size": 1362890}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24", "submissionTracking": {"firstMcpInfo": {"postDateStruct": {"date": "2022-12-21", "type": "ACTUAL"}}}}, "conditionBrowseModule": {"meshes": [{"id": "D000001249", "term": "Asthma"}], "ancestors": [{"id": "D000001982", "term": "Bronchial Diseases"}, {"id": "D000012140", "term": "Respiratory Tract Diseases"}, {"id": "D000008173", "term": "Lung Diseases, Obstructive"}, {"id": "D000008171", "term": "Lung Diseases"}, {"id": "D000012130", "term": "Respiratory Hypersensitivity"}, {"id": "D000006969", "term": "Hypersensitivity, Immediate"}, {"id": "D000006967", "term": "Hypersensitivity"}, {"id": "D000007154", "term": "Immune System Diseases"}], "browseLeaves": [{"id": "M4556", "name": "Asthma", "asFound": "Asthma", "relevance": "HIGH"}, {"id": "M5258", "name": "Bronchial Diseases", "relevance": "LOW"}, {"id": "M14977", "name": "Respiratory Tract Diseases", "relevance": "LOW"}, {"id": "M11168", "name": "Lung Diseases", "relevance": "LOW"}, {"id": "M11170", "name": "Lung Diseases, Obstructive", "relevance": "LOW"}, {"id": "M10018", "name": "Hypersensitivity", "relevance": "LOW"}, {"id": "M14967", "name": "Respiratory Hypersensitivity", "relevance": "LOW"}, {"id": "M10020", "name": "Hypersensitivity, Immediate", "relevance": "LOW"}, {"id": "M10200", "name": "Immune System Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC20", "name": "Immune System Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}}, "hasResults": true}